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1. Introduction  
No effective drugs are currently available for the treatment of mental diseases, primarily 
because the underlying mechanism of mental diseases have not been adequately explored at 
the molecular level. However, recent studies have examined several molecular cascades 
whose disturbances are associated with mental diseases such as schizophrenia, bipolar 
disease and major depression. The most common characteristics of these cascades us that 
they are all associated with neural circuit formation, suggesting that neurodevelopmental 
factors play a key role in the pathogenesis of mental diseases. The present review 
summarizes the available information on these molecular cascades and their association 
with mental disease. 
2. Molecular mechanism of PACAP-stathmin1 dependent psychiatric 
disorders (Yamada et al., 2010) 
Pituitary adenylate cyclase polypeptide (PACAP) is involved in multiple brain function 
such as neurotransmission and neural plasticity (Hashimoto et al., 2001; Vaudry et al., 2000). 
It also has a neurotrophic effect via three heptahekical G protein coupled receptors, one of 
which is specific for PACAP (PAC1 receptor) and two others that are shared with vasoactive 
intestinal polypeptide (VPAC1 and VPAC2) (Hashimoto et al., 1993). Recently, mice that lack 
Adcyap 1, the gene encoding PACAP, (Adcyap 1-/- mice) were developed (Hashimoto et al., 
2001, Shintani et al., 2002). Adcyap 1-/- mice display remarkable behavioral abnormalities 
providing evidence that PACAP plays a previously uncharacterized role in the regulation of 
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psychomotor behavior.  In addition, previous association study reported that several single 
nucleotide polymorphism (SNPs) in the vicinity of the PACAP gene locus were associated 
with schizophrenia (Hashimoto, R. et al., 2007). However, although nothing was known 
about the mechanism of PACAP deficiency-induced psychiatric illness, we have clarified 
these mechanisms. 
2.1 Down-regulation of PACAP expression induces up-regulation of stathmin1 
expression in the dentate gyrus both in vivo and in vitro 
Real-time PCR showed that stathmin1 mRNA was markedly increased in the dentate gyrus 
of Adcyap 1-/- mice. An increased in stathmin1 protein levels in the dentate gyrus of Adcyap 1-
/- mice was confirmed by western blot analysis. These findings were confirmed also in vitro 
using PC12 cells. PACAP stimulation of PC12 cells caused a decrease in stathmin1 mRNA 
levels after 3 h, and expression continued to decrease over the next 24 h (Fig. 1A). Stathmin1 
protein levels also decreased in response to PACAP, which caused a dose-dependent 
decrease of stathmin1 mRNA levels. The decrease of stathmin1 expression caused by 
PACAP stimulation was slightly, but statistically significantly, inhibited by pretreatment 
with a PAC1/VPAC2 receptor antagonist (PACAP6-38). In addition, pretreatment with a p38 
antagonist (SB202190) or an ERK antagonist (PD98059) also inhibited the PACAP-induced 
decrease of stathmin1 expression. Co-administration of SB202190 and PD98059 strongly 
inhibited the effect of PACAP, reflecting the key roles played by p38 and ERK in the PACAP 
signaling pathway. On the other hand, VIP did not decrease stathmin1 expression. These 
results indicate that PACAP regulates stathmin1 expression via the PAC1 receptor in 
neurons of the dentate gyrus. 
2.2 Up-regulation of stathmin1 induces abnormal axonal arborization in neurons of 
the dentate gyrus subgranular zone 
In wild-type mice, cells expressing stathmin1 were preferentially located in the innermost 
part of the granular cell layer, the so-called subgranular zone (SGZ), where neurogenesis of 
granular cells occurs in adults. Two types of stathmin1 containing processes were found, 
namely; dendrites and axons. Immunoreactivity for stathmin1 was significantly increased in 
the SGZ neurons of Adcyap 1-/- mice, although the actual number of immunoreactive cells 
was similar in mutant and wild-type mice. . The number of dot-like immunoreactive fibers 
belonging to axons was significantly increased in the polymorphic layer of Adcyap 1-/- mice, 
compared with wild-type mice. In support of the in vivo datas, over-expression of stathmin1 
in the hippocampal primary culture neurons caused dramatic changes of axon fibers. 
Arborization of axon fibers was markedly increased by stathmin1 over-expression 
compared with that in normal primary cultured neurons. The number of secondary neurites 
on axons was also increased following over-expression of stathmin1. These findings 
indicated that an increase in stathmin1 expression in SGZ neurons leads to abnormal axon 
arborization. 
If PACAP directly regulates stathmin1 expression in vivo, SGZ neurons should express 
PAC1. In fact, strong expression of PAC1 mRNA was identified throughout the entire 
granular cell layer, including the SGZ. Furthermore, SGZ neurons expressed both stathmin1 
protein and PAC1 mRNA. These results show that PACAP inhibits stathmin1 expression via 
the PAC1 receptor. 
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Fig. 1. PACAP-stathmin1 cascade 
A: PACAP regulated stathmin1 expression via PAC1 in PC12 cells. Alteration of stathmin1 
mRNA levels 24 h after PACAP treatment, at the indicated concentrations were quantified 
by real-time PRC. Data are expressed as mean ±SEM relative to control values (n=3, PACAP 
1nM **P=0.0044, 10nM **P=0.0033, 100nM ***P=0.0003 compared with control. B,C; 
Stathmin1 over-expression in neurons caused abnormally pronounced arborization of axon 
fibers. Morphology of hippocampal primary neurons transfected with stathmin1. Over-
expression of GFP (B) and GFP-stathmin1 (C). The neurons over-expressing stathmin1 have 
abnormally pronounced sprouting of axon fibers. D: Schematic drawing of the molecular 
pathway underlying PACAP regulation of stathmin1 expression.  The schematic 
representation shows the pathway by which PACAP regulates the expression of stathmin1 
by suppressing the function and expression of Ascl1 after increasing the expression of Hes1 
and Id3 by activating ERK and p38. 
2.2.1 Stathmin1 gene promoter activity is regulated by basic helix loop helix (bHLH) 
proteins via the E10 box  
A BLAST search identified the genomic sequence of rat stathmin1 in a chromosome 5 contig. 
PCR amplification of a 1885bp genomic DNA fragment that consisted of 1561 nt upstream of 
the stathmin1 transcription start site (+1), exon1, and part of intron 1 (+325) was then 
performed. This fragment was sequenced and subcloned into a pGL3 luciferase reporter 
vector. This fragment was also analyzed for transcription factor-binding sites using the 
DNAsis program. The 1.8kbp rat stathmin1 5' genomic sequence contained 12 (E1-E12) 
putative E boxes (CANNTG), which are potential binding sites for bHLH proteins, 
including neuronal transcription activators. To investigate the promoter activity of 
stathmin1, we constructed several expression plasmids for the luciferase assay after 
transient transfection in PC12 cells. Constructs containing E10  (such as STMN1-1, STMN1-2 
and STMN 1-3) showed a high level of luciferase activity compared with control cells, but 
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constructs containing a stathmin promoter lacking the E10 box (such as STMN1-4) did not 
show luciferase activity. Therefore, the E10 box was found to be a key motif that regulates 
stathmin1 expression through bHLH factors. 
2.2.2 An activating bHLH protein, Ascl1, activates the stathmin promoter 
Among activating bHLH proteins, Ascl1was found to activate the stathmin1 promoter. Co-
transfection of PC12 cells with the stathmin1-promoter plasmid and the Ascl1 expression 
plasmid induced a dose-dependent increase in luciferase activity compared with cells 
transfected with the stathmin1 promoter plasmid alone. To examine whether endogenous 
Ascl1 protein could bind to the stathmin1 promoter sequence in PC12 cells, sheared 
chromatin was immunoprecipitated with an anti-Ascl1 antibody or with control IgG, 
followed by PCR amplification of the corresponding DNA regions using stathmin1 
promoter specific primers. Analysis of amplified DNA showed that more sequences were 
amplified by primers flanking the E10 box than by primers flanking the E10-E11 boxes. In 
addition, co-localization of Ascl1 and stathmin1 in SGZ neurons was demonstrated by 
immunohistochemistry. These results established that endogenous Ascl1 protein binds to 
stathmin1 promoter and act as a major regulator of stathmin1 promoter activity.  
2.2.3 The inhibitory bHLH proteins, Hes1 and Id3, showed increased expression after 
PACAP stimulation 
As described above, PACAP inhibits stathmin1 expression. In addition, PACAP stimulation 
of PC12 cells caused an increase in the expression of the inhibitory HLH proteins,  Hes1 and 
Id3 expression which belong to inhibitory HLH proteins.  Inhibition of the PACAP signaling 
pathway, as through the inhibition of p38 and ERK, suppresses the effect of PACAP on 
stathmin1 expression. Moreover, the increase of Id3 mRNA levels in response to PACAP 
stimulation was inhibited by a p38 inhibitor (SB202190), but not by an ERK inhibitor 
(PD98059), while induction of Hes1 mRNA by PACAP stimulation was inhibited by both an 
ERK inhibitor and a p38 inhibitor. Co-administration of p38 and ERK inhibitors strongly 
inhibited thePACAP-induced induction of Hes1 mRNA. These findings showed that Hes1 
expression is regulated by both the PACAP-ERK and PACAP-p38 pathways, whereas Id3 
expression is mainly controlled by the PACAP-p38 pathway. 
2.2.4 Hes1 and Id3 suppress stathmin1 promoter activity via Ascl1 inhibition 
PC12 cells were co-transfected with a stathmin1 promoter plasmid and a Hes1 expression 
plasmid or an Id3 expression plasmid with or without an Ascl1 expression plasmid. Even 
without exogenous Ascl1 expression, a high level of luciferase activity was detected, owing 
to the action of the stathmin1 promoter. Expression of Hes1 or Id3 in these cells inhibited 
luciferase activity related to the stathmin1 promoter activity through endogenous Ascl1. In 
PC12 cells transfected with the stathmin1 promoter plasmid and the Ascl1 expression 
plasmid, luciferase activity was higher than that in PC12 cells without the Ascl1 expression 
plasmid. Id3 expression in these cells inhibited the up-regulation of stathmin1 promoter 
luciferase activity, while Hes1 expression failed to reduce the luciferase activity induced by 
exogenous Ascl1.These findings suggested that Id3 inhibits activation of the stathmin1 
promoter by both exogenous and endogenous Ascl1, while Hes1 only blocked the effect of 
endogenous Ascl1. Thus, it is likely that Id3 regulates Ascl1 at the protein level, while Hes1 
regulates Ascl1 transcription. If so, inhibition of Hes1 expression should increase the 
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transcription of Ascl1. In fact, the up-regulation of Hes1 in PC12 cells by PACAP stimulation 
led to inhibition of Ascl1 expression. In addition,  a reduction of Hes1 expression also 
resulted in an elevation of Ascl1 expression to 1.2 fold the control level. These results 
indicate that Ascl1, which controls stathmin1 expression, was functionally regulated by Id3 
and quantitatively regulated by Hes1, in response to PACAP signaling. 
2.3 Role of the PACAP-stathmin1 cascade in psychiatric disorders 
As described above, PACAP inhibits stathmin1 expression. In addition, over-expression of 
stathmin1 causes abnormal axonal arborization (Fig. 1B,C), indicating that stathmin1 
regulates the maturation of neurons and neural circuit formation. Furtehrmore, Adcyap 1-/- 
mice are known to show behavioral abnormalities, some of which might have potential 
relevance to mental disorders such as schizophrenia (Hashimoto et al.,2001; Shintani et al., 
2002), and several SNPs in the vicinity of the PACAP  gene locus are associated with 
schizophrenia (Hashimoto et al., 2007). If so, stathmin1 expression should be altered in the 
brain of patients with schizophrenia. Our RT-PCR study showed that stathmin1 mRNA 
levels were significantly increased in schizophrenic patients compared with age-matched 
controls. In contrast, stathmin1 was not significantly increased in the brains of patients with 
bipolar disorder. 
3. Mechanism of PACAP-DBZ/DISC1 dependent psychiatric disorders  
(Hattori et al.,2007; Katayama et al., 2009) 
DBZ (DISC1-binding zinc finger protein) was found as a DISC1(disrupted-in schizophrenia 
1)-interacting molecules by yeast-2-hybrid screening of a complementary DNA (cDNA) 
library. Subsequent co-immunoprecipitation studies and yeast-2 hybrid assays showed that 
amino acids 348-597 of DISC1 act as the DBZ binding region, which indicates that the 
regions of DISC1 near the translocation breakpoint (amino acid 598) participate in the 
interaction with DBZ. DISC1 and DBZ co-localize diffusely in the cytoplasm and 
centrosome, and are involved in neurite extension. PACAP regulates the association 
between DISC1 and DBZ (for details on DISC1, see the chapter 6). 
3.1 DISC1-DBZ interaction inhibits the neurite outgrowth (Fig.2) 
DBZ mRNA was expressed exclusively in the brain, but was not expressed in peripheral 
tissues. To examine the functional role of the DISC1-DBZ interaction, PC12 cells stably 
expressing DISC1-HA and mock-transfected cells were infected with Adv-DBZ-GFP or Adv-
GFP for 24 h. Immunoprecipitation and western blot analysis confirmed the over-expression 
of DBZ-GFP and DISC1-HA as well as the association between these 2 molecules. Over-
expression of both proteins in PC12 cells caused a significant reduction in the number of 
neurite bearing PC12 cells after PACAP stimulation. However, over-expression of either 
DBZ or DISC1 alone had no effect. The region of DBZ encompassing amino acids 152-301 
interacts with DISC1. PC12 cells were transiently transfected with DBZ (152-301)-IRES-GFP 
or with GFP alone and treated with PACAP (100nM) for 48 h. The cells expressing DBZ 
(152-301) had a shorter neurite length than cells expressing GFP alone. Under these 
conditions, no significant change of apoptosis was detected and the number of transfected 
cells was similar. The effect of DBZ (152-301) on neurite growth was also confirmed in 
primary cultured hippocampal neurons. 
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Fig. 2. A: Neurite outgrowth was inhibited by the DISC1-binding domain of DBZ [DBZ(152-
301)-IRES-GFP].  PC12 cells were transfected with DBZ (152-301)-IRES-GFP or GFP alone at 
2 days after plating. After 24 h , cells were starved of serum for 4h and treated with 100nM 
PACAP for 48h. Phase-contrast and fluorescence microscopy images are shown. Diagrams 
display neurite length relative to cell body diameter of transfected PC12 cells. B: PACAP-
induced transient inhibition of the endogenous DISC1-DBZ interaction in PC12 cells. 
Immunoprecipitation and ｗestern blot analysis (with anti-DISC1 or anti-DBZ antibodies) of 
PC12 cells lysates collected at the indicated times after stimulation with 100nM PACAP. 
Immunoprecipitaes obtained with an anti-DBZ antibody incubated with 5% of each lysates 
(5% input), were subjected to western blot analysis with the same antibody.  Quantitation of 
relative band densities for DISC1 co-immunoprecipitated with DBZ, as well as for total 
DISC1 or DBZ protein, was performed by scanning densitometry. Data were expressed as 
the mean ±SEM. of at least ３ independent experiments. *P<0.05 vs control  (Student’s t-
test). C: A possible PACAP-DISC1/DBZ pathway . In the normal brain, PACAP leads to the 
temporal dissociation of the binding between DISC1 and DBZ , which in turn leads to 
normal neurite outgrowth. In the brain of schizophrenia patients, DBZ cannot bind to 
DISC1, and the PACAP pathway may proceed without inhibition, resulting in the formation 
of an abnormal neural circuit. 
3.2 PACAP regulates DISC1-DBZ binding (Fig. 2) 
Exposure to PACAP (100nM) increased the expression of endogenous DISC1 in PC12 cells 
by about 50% after 24 h, whereas it had no effect on DBZ expression. PACAP has a marked 
influence on the interaction between DBZ and DISC1. The co-immunoprecipitation of DISC1 
and DBZ from PC12 cell lysates was reduced by approximately 80% 1h after treatment of 
cells with PACAP (100nM). However, this reduction was transient and there was a gradual 
return to control level by 24 h after treatment. Addition of an ERK inhibitor 24 h after 
PACAP treatment inhibited the rebinding of DBZ to DISC1, while an inhibitor of adenyl 
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cyclase failed to influence the DISC1-DBZ interaction, showing that PACAP regulates 
DISC1-DBZ binding through the ERK cascade but not through the cAMP cascade. 
3.3 Role of the PACAP-DBZ cascade with regard to PACAP-DBZ/DISC1 dependent 
psychiatric disorders (Fig.2) 
The findings described above show that the DISC1-DBZ interaction inhibits neurite out 
growth, and PACAP dissociates this interaction, resulting in neurite outgrowth. The 
involvement of the DISC1-DBZ interaction and PACAP in neurite outgrowth suggests that 
these molecules should be expressed in the early ontogenetical stages. In fact, a marked 
elevation of both DBZ and PAC1 (PACAP receptor) expression was observed during the 
perinatal stage (Hattori et al. in preparation). DISC1 shows a high level of expression in the 
developing cortex and hippocampus (Honda et al.,2004). In addition, down-regulation of 
DBZ caused a delay in the migration of cortical neurons (Sato et al., personal 
communication) and disturbance of cilia formation (Kumamoto et al., in preparation). The 
DISC1-DBZ interaction which is regulated by PACAP has therefore been shown to be 
involved in neurite out growth and the migration of neurons. In the brain of patients with 
PACAP-dependent psychiatric disorders, dissociation of the binding between DISC1 and 
DBZ does not occur and neurite extension may be inhibited. On the other hand, in brains in 
which translocation of DISC1 occurs, DBZ is unable bind to DISC1 and the dissociation of 
DISC1 from DBZ may not be induced, which results in an immature neural circuit. 
4. Molecular mechanism of Dysbindin-MARCKS cascade dependent 
psychiatric disorders (Okuda et al., 2010) 
Studies of postmortem brain tissue showed decreased Dysbindin (dystrobrevin binding 
protein 1; DTNBP1) protein and mRNA levels in patients with schizophrenia compared 
with controls (Bray et al., 2005; Talbot et al., 2004; Weickert et al., 2004). Chronic treatment of 
mice with antipsychotics did not affect the levels of Dysbindin protein and mRNA 
expression in their brains (Chiba et al., 2006; Talbot et al., 2004), suggesting the lower levels 
of Dysbindin protein and mRNA found in the postmortem brains of schizophrenia patients 
is not likely to be a simple artifact of antemortem drug treatment. In addition, several 
studies suggested that diverse high-risk SNPs and haplotypes could influence Dysbindin 
mRNA expression (Bray et al., 2005; Talbot et al., 2004; Weickert et al., 2004). These data 
indicate that the Dysbindin gene may confer susceptibility to schizophrenia through reduced 
Dysbindin expression. However, the molecular mechanisms underlying the effect of 
decreased Dysbindin expression on vulnerability to schizophrenia remain unknown. 
4.1 Dysbindin- myristoylated alanin-rich protein kinase C substrate (MARCKS) 
cascade (Okuda et al., 2010) 
4.1.1 Dysbindin exists within the nucleus in addition to the cytoplasm  
Cell fractionation experiments using Dysbindin-FLAG-overexpressing HEK293 cells showed 
that Dysbindin exists mainly in the cytosol while a small amount is present in the nucleus. 
Immunohistochemical analysis also revealed that Dysbindin is localized mainly in the 
cytoplasm with a perinuclear high density region. However, a faint immunoreaction was 
seen within the nucleus. Furthermore, pretreatment with leptomycine-B(LPB), which 
inhibits the export of proteins from the nucleus to the cytoplasm, caused a slight increase of 
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Dysbindin and its nuclear localization. These findings show that the Dysbindin protein is 
shuttled between the nucleus and the cytoplasm. 
4.1.2 Dysbindin binds to the transcription factor NF-YB 
Using yeast 2-hybrid screening, several transcriptional factors including nuclear 
transcription factor Y beta (NF-YB), were identified as candidates for interaction with 
Dysbindin. NF-YB belong to a family of CCAAT-binding transcription factors that are 
important for the basal transcription of a class of regulatory genes and are involved in 
cellular reactions. HEK293T cells which express NF-YB endogenously were transfected 
with expression vectors for Dysbindin-V5 and subjected to immunoprecipitation to confirm 
the Dysbindin-NF-YB interaction. In addition, the Dysbindin-NF-YB interaction was shown 
in lysates from SH-SY5Y cells, which express both Dysbindin and NF-YB endogenously, as 
well as adult mouse brain lysates. 
4.1.3 Downregulation of Dysbindin causes up-regulation of the expression level of 
MARCKS 
The interaction between Dysbindin and NF-YB suggests that Dysbindin may be functionally 
involved in the transcription of genes regulated by NF-YB. We therefore screened for genes 
displaying altered expression by means of a DNA chip, using RNA extracts from the 
Dysbindin or NF-YB knockdown human neural cell line, SH-SY5Y. Among them identified, 
we focused on MARCKS, because protein kinase C has been involved in psychiatric diseases 
and because the promoter region of the MARCKS gene has the CCAAT binding motif 
specific for NF-YB. 
The effect of Dysbindin on MARCKS in vitro was confirmed in vivo by examining the 
expression of the MARCKS protein product in the hippocampus of Dysbindin knockout 
mice with advanced age and comparing the levels with those of wild-type mice. In wild-
type mice, a peak in MARCKS protein expression in the hippocampus was detected on 
postnatal days 15 and 20, and with a marked decrease in expression levels over time. 
However, this decrease was not observed in Dysbindin knockout mice, suggesting that 
down-regulation of Dysbindin may enhance the transcription of the MARCKS protein. 
Chromatin immunoprecipitation analysis using SH-SY5Y cells over-expressing Dysbindin-
Flag, was performed to explore the possibility that the Dysbindin-NF-YB complex could 
affect the transcription of MARCKS via interaction with the promoter region of MARCKS. 
PCR products from the chromatin immunoprecipitates suggested that Dysbindin and NF-
YB simultaneously interact with the promoter region of MARCKS. These results indicate 
that the Dysbindin-NF-YB complex interacts with the promoter region of the MARCKS gene 
resulting in inhibition of MARCKS transcription. 
4.1.4 The transcriptional level of the MARCKS gene is regulated by Dysbindin via the 
NF-YB binding motif, CCAAT-2 
The 5'-UTR region of the MARCKS  gene has 2 kinds of CCAAT sequences, namely; one 
CCAAT motif located between residues -1152 and -700 (CCAAT-1) and one located between 
UTR -700 and -614 (CCAAT-2). Because NF-YB binds to the CCAAT motif to regulate the 
transcription of target genes，the role of the CCAAT motifs in the regulation of MARCKS 
transcription was examined by luciferase assay with 5 vectors containing shorter RNA 
probes (Fig. 3A);  These vectors were UTR(1152)-Luc, UTR (953)-Luc, UTR (700)-Luc, UTR 
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(614)-Luc, and UTR (462)-Luc. The luciferase activity detected in SH-SY5Y cells expressing 
the UTR (1152)-Luc after retinoic acid stimulation was used as a baseline. In the cells 
transfected with UTR (953)-Luc containing both CCAAT sequence and UTR (700)-Luc 
containing CCAAT-1 sequence but lacking the CCAAT-2 sequence, luciferase activity 
remained at baseline level after stimulation with retinoic acid. However luciferase activity 
was markedly increased in cells expressing UTR (614)-Luc after retinoic acid stimulation. 
These results suggest that the CCAAT-2 motif plays an important role in the inhibition of 
MARCKS transcription.  Furthermore, SH-SY5Y cells transfected with UTR (462)-Luc 
lacking CCAAT-1, CCAAT-2 and SP1 region showed very low luciferase activity, indicating 
that the SP1 is indispensable for MARCKS transcription. 
To confirm that the CCAAT-2 region is important for the regulation of MARCKS 
transcription, several probes were designed for the luciferase assay (Fig. 3Ｂ), namely; D1-
UTR (1152)-Luc which lacks the CCAAT-2 motif and its downstream region including Sp1 
from UTR (1152)-Luc, D2-UTR (1152)-Luc which lacks the SP1 region and the downstream 
sequence from UTR (1152)-Luc, D3-UTR (1152)-Luc which lacks only the sequence 
downstream of the SP1 region, D4-UTR (1152)-Luc which lacks only the CCAAT motif from 
UTR (1152)-Luc, and M-UTR(1152)-Luc, which has a point mutation in the CCAAT-2 motif. 
Luciferase activity was detected in SH-SY5Y cells transfected with each probe, using the 
activity in cells transfected with UTR (1152)-Luc as the baseline value. Cells transfected with 
M-UTR (1152)-Luc and those transfected with D4-UTR (1152)-Luc exhibited marked 
increases in luciferase activity, showing that the CCAAT-2 motif plays a key role in the 
inhibition of MARCKS transcription. Furthermore, cells expressing D1-UTR (1152)-Luc, D2-
UTR (1152)-Luc or D3-UTR (1152)-Luc exhibited no luciferase activity. These findings 
suggest that the sequence downstream of the Sp1 region, and the Sp1 region itself, 
areindispensable for MARCKS transcription. 
To confirm the involvement of Dysbindin in the altered MARCKS transcription levels via 
the CCAAT-2 motif, we compared the luciferase activity of UTR (1152)-Luc detected in 
Dysbindin knockdown cells with that of control cells. Knockdown of Dysbindin resulted in 
the up-regulation of luciferase activity in the UTR (1152)-Luc transfected cells. However, the 
effect of knockdown of Dysbindin knockdown on luciferase activity was not observed in 
D1-UTR (1152)-Luc transfected cells. These results suggest that Dysbindin regulates 
MARCKS transcription via the NF-YB binding motif CCAAT-2. On the other hand, the 
negligible levels of luciferase activity observed in cells transfected with probes lacking the 
sequence downstream of the Sp1 region, suggest that this this sequence is essential for 
MARCKS  transcription. In fact, knockdown of Dysbindin caused the up-regulation of 
MARCKS expression (Fig. 3C). 
4.2 Role of the Dysbindin-MARCKS cascade in psychiatric disorders (Fig. 3D) 
SNPs in Dysbindin have been associated with intermediate cognitive phenotypes related to 
schizophrenia such as IQ and working and episodic memory, and a Dysbindin haplotype 
has been associated with higher educational attainment  (Corvin et al., 2008; Donohoe et al., 
2007). In addition, several papers show evidence of the involvement of Dysbindin in 
cognitive functions (Burdick et al., 2006; Zinkstok et al., 2007).  
Furthermore, accumulating evidence suggests the involvement of Dysbindin in 
neurotransmission. At the cellular level, Dysbindin is located at both pre- and post-synaptic 
terminals., and is thought to be involved in postsynaptic density function and the 
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Fig. 3. A,B: Dysbindin regulates the transcription of MARCKSvia the CCAAT-2 sequence. A:  
The following 5 vectors contaiing shorter DNA probes were used for the  luciferase assay; 
UTR(1152)-Luc, UTR (953)-Luc, UTR (700)-Luc, UTR (614)-Luc, and UTR (462)-Luc. Vectors 
were transfected into SH-SY5Y cells and luciferase activity was measured. The luciferase 
activity of UTR (1152) was used as the control. Columns and vertical bars denote the means 
±SEM (triplicate independent experiments). B: The UTR (1152)-Luc vector and deletion or 
point mutations of the UTR (1152)-Luc vectors, [D10UTR(1152)-Luc], [D2-UTR (1152)-Luc], 
[D3-UTR (1152)-Luc], [D4-UTR(1152)-Luc] and [M-UTR (1152)-Luc], were transfected into 
SH-SY5Y cells and luciferase activity was measured. [D4-UTR(1152)-Luc], which lacks 
CCAAT-2, and [M-UTR (1152)-Luc], which has a point mutation in the CCAAT-2 sequence, 
showed increased luciferase activity. The luciferase activity of UTR (1152) was used as the 
control. Columns and vertical bars denote the means ±SEM(triplicate independent 
experiments). C: Dysbindin knockdown results in the up-regulation of MARCKS. SH-SY5Y 
cells were transfected with scrambled RNAi or siRNA for Dysbindin. Cell lysate of un-
treated cells (cont.), scrambled RNAi-transfected  cells (Scr.) and RNAi for Dysbindin-
transfected cells (siRNA) were subjected to western blotting with an anti-MARCKS 
antibody. Columns and vertical bars denote the means ±SEM(triplicate independent 
experiments). Dysbindin knockdown cells exhibited significant up-regulation of MARCKS 
expression compared with control cells (P<0.001, Student’s t-test). D: A possible Dysbindin 
pathway related to the regulation of dopamine release. In the cytoplasm of the nigrostriatal 
dopamine neurons, Dysbindin binds to Snapin. This binding inhibits the expression of 
SNAP25, which may suppress dopamine release. In the nuclei of these neurons, Dysbindin 
inhibits MARCKS expression via the binding to NF-YB. Reduction of MARCKS expression 
in dopaminergic neurons may causes the down-regulation of dopamine transport from the 
soma to the terminal. Thus Dysbindin inhibits dopamine release by 2 pathway. 
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trafficking of receptors (NMDA,GABAergic and nicotinic) (Sillitoe et al., 2003; Talbot et al., 
2004). Over-expression of Dysbindin increases glutamate release from pyramidal neurons in 
cell culture, possibly because of its role in vesicular trafficking (Numakawa et al., 2004). 
Decreases in Dysbindin mRNA and protein levels have been reported in regions previously 
implicated in schizophrenia such as the prefrontal; cortex, midbrain and hippocampus (Talbot 
et al., 2004; Weickert et al., 2004). On the other hand, abnormal activation of nigrostriatal and 
mesolimbic dopaminergic systems is thought to be one of the most important etiologies for 
schizophrenia (Angrist & van Kammen, 1984; Creese et al., 1976; Lieberman et al., 1987; 
Seeman &Lee, 1975), suggesting a functional relationship between dopamine and Dysbindin. 
In support of this, midbrain dopamine neurons also contain Dysbindin (Kumamoto et al., 
2006). Suppression of Dysbindin expression in PC12 cells resulted in an increase of the 
expression of SNAP25 which plays an important role in neurotransmitter release, and 
increased the release of dopamine. On the other hand, up-regulation of Dysbindin expression 
in PC12 cells showed a tendency to decrease the expression of SNAP25 and the release of 
dopamine. These findings show that Dysbindin inhibits dopamine release via down-
regulation of SNAP25 expression (Kumamoto et al., 2006). 
Thus, Dysbindin inhibits MARCKS expression and decreased expression of Dysbindin is 
characteristic of the schizophrenic brain. In addition, a decrease in Dysbindin levels up-
regulates dopamine release. MARCKS influences neurotransmission via F-actin and 
vesicular transport via synaptic vesicles. The enhanced dopaminergic transmission 
produced by the lower expression level of Dysbindin may be partially attributed to 
activation of MARCKS. Thus, the impairment of neuronal transmission in the schizophrenic 
brain may be caused by alterations of MARCKS expression levels via changes in Dysbindin. 
Sandy (sdy) mice that express no Dysbindin, showed behavioral abnormalities, which could 
be endophenotypes of schizophrenia (Feng et al., 2008). These mutant mice reportedly 
exhibit defective synaptic structure and function of CA1 neurons (Chen  et al., 2008), though 
the mechanism by which the loss of Dysbindin induces schizophrenia-like behaviors, 
remains unclear.  Recently, we revealed that Dysbindin is involved in neural development 
through the regulation of the actin skeleton organization (Kubota et al., 2008). This study 
showed that knockdown of Dysbindin resulted in the aberrant organization of the actin 
cytoskeleton in SH-SY5Y cells. Furthermore, morphological abnormalities of the actin 
cytoskeleton were similarly observed in growth cones of cultured hippocampal neurons 
derived from sdy mice. In addition, a significant correlation was found between Dysbindin 
expression levels and the phosphorylation level of c-Jun N-terminal kinase (JNK), which is 
implicated in the regulation of cytoskeletal organization. These findings revealed that 
Dysbindin plays a key role in coordinating JNK signaling and actin cytoskeleton 
organization, which are required for neuronal development. 
5. Mechanism of tumor necrosis factor receptor (TNFR) associated  
protein 1 (TRAP1)-N-cadherin alteration-induced psychiatric disorders  
An increase in serum tumor necrosis factor-┙ (TNF-┙) level is closely related to the 
pathogenesis of major depression (Irwin & Miller, 2007). The tumor necrosis factor receptor 
assoicated protein (TRAP1) was detected in whole brain lysates (Song et al., 1995). TRAP1 is 
a member of the heat shock protein 90 (HSP90) family and possesses ATPase activity, but 
lacks chaperone activity (Felts et al., 2000). However, the function and molecular mechanism 
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of the TNF-TRAP system remain unclear. In the following section, we will describe the 
evidence that TRAP1 regulates the expression of adhesion molecule (Kubota et al., 2009). 
5.1 TRAP1 is widely expressed in neurons through the brain, including in regions 
known to be affected in patients with major depression 
In situ hybridization histochemistry and immunocytochemistry revealed that TRAP1 
mRNA and protein are broadly expressed in neurons throughout the gray matter of the 
brain and the spinal cord, including in regions known to be affected in patients with major 
depression patients, such as the medial prefrontal cortex, hippocampus and nuclei 
producing monoamine: the substantia nigra pars compacta, dorsal raphe nucleus and locus 
ceruleus (Nestler et al., 2002; Berton and Nestler, 2006). However, glial cells such as 
astrocytes and oligodendrocytes are devoid of TRAP1. In addition, punctate 
immunostaining of TRAP1 was detected in the cytoplasm, which is consistent with 
previously reported mitochondrial localization of TRAP1 in a cell culture (Felts et al., 2000).  
5.2 TRAP1 regulates cell adhesion 
A striking cell-scattering phenotype was observed in TRAP1 knockdown SH-SY5Y cells. 
Cells transfected with siTRAP1 were dispersed throughout the dish, compared to cells 
transfected with control siRNA, which grew in aggregates resembling untransfected SH-
SY5Y cells (Fig. 4A,B). This phenomenon was detectable as early as 24 h after transfection 
and became more prominent by 72 h after transfection. Immunostaining of actin filaments in 
siRNA-treated cells showed no difference in cytoskeletal structure. Quantification of the 
percentage of cells with no inter-cellular contacts after staining for actin detected a 6.2-fold 
increase in cells transfected with siTRAP1(36%) compared to cells transfected with control 
siRNA (5.8%). The cell aggregation assay revealed that TRAP1 knockdown cells were 
characterized by decreased efficacy of cell-cell adhesion compared with control cells, 
suggesting an alteration in calcium-dependent cell adhesion is affected. These results 
strongly indicate that TRAP1 regulates downstream molecules crucial for cell adhesion. 
5.3 N-cadherin is transcriptionally down-regulated in TRAP1 knockdown cells 
Expression levels of cell adhesion molecules, including N-cadherin, are directly related to 
the cell-scattering phenomenon (Hayashida et al., 2006; Yasuda et al., 2007) and N-cadherin 
mediates calcium-dependent cell adhesion in neuronal cells (Takeuchi and Nakagawa, 2007) 
Our findings showed that N-cadherin levels were remarkably decreased throughout the 
cytoplasm of TRAP1 knockdown cells, including around the membrane where cell-adhesion 
takes place, compared to control cells (Fig. 4C,D). Immunoblotting experiments confirmed 
this finding, showing a significant decrease in N-cadherin expression in TRAP1 knockdown 
cells  from as early as 24 h until at least 2 h after transfection. However, the expression level 
of ┚-catenin, which is involved in the regulation of cell-adhesion, was unaffected. These 
results suggest that the cell scattering phenotype  detected in TRAP1 knockdown cell is at 
least partially mediated by a reduction of N-cadherin expression in those cells. 
To exclude the possibility that cell viability or migration may contributes to the cell-
scattering phenotype in TRAP1 knockdown cells, we examined cell viability by the 3-(4,5-
dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and migration by the 
wound-healing assay. Although a slight decrease in cell viability was observed  in TRAP1 
knockdown cells compared to control cells 48 h after transfection or later, no changes were 
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detected 24 h after transfection, when the cell-scattering phenotype of TRAP1 was already 
observed. No significant changes in the rate of cell migration were observed.  
To determine if down-regulation of N-cadherin induced by siTRAP1 occurs at the 
transcriptional level, N-cadherin mRNA levels were measured by real-time RT-PCR analysis 
48 h after siRNA transfection, which showed that N-cadherin mRNA levels in TRAP1 
knockdown cells were approximately 45% lower than in control cells. These results indicate 
that TRAP1 knockdown induces transcriptional down-regulation of N-cadherin. 
5.4 E2F1, a putative transcription factor of N-cadherin, is down-regulated in TRAP1 
knockdown cells 
To determine the possible involvement of a transcription factor in down-regulation of N-
cadherin in TRAP1 knockdown cells, a search DBTSS (Database of Transcriptional Start 
Sites) and TRANSFAC (The Transcription Factor Database) database was conducted. This 
search revealed a putative binding site for E2F1 in the promoter region of the N-cadherin 
gene. Immunoblot analysis and real-time PCR showed that E2F1 mRNA and protein levels 
were significantly decreased in TRAP1 knockdown cells (Fig. 4E), although the mRNA level 
of c-Myc, another representative transcription factor, was not affected, In addition, SH-SY5Y 
cells transfected with the N-cadherin-luciferase plasmid showed strong activity of the 
reporter, and this activity was suppressed in TRAP1 knockdown cells, mimicking the 
signaling cascade detected in vitro. Furthermore, exogenously transfected E2F1 showed a 
7.5-fold induction of luciferase reporter activity relative to the control vector. These results 
indicate that E2F1 plays a regulatory role upstream of N-cadherin in TRAP1 knockdown 
cells. 
5.5 Reduced phosphorylation of STAT causes down-regulation of E2F1 in TRAP1 
knockdown cells 
A recognition sequence for STAT3 is located 89bp upstream of the transcription initiation 
site of the E2F1 gene. Upon activation, STAT3 proteins are tyrosine-phosphorylated, 
dimerize and translocate to the nucleus where the nuclear phospho-STAT binds to STAT 
recognition sites located in the promoter region of downstream genes to promote the 
transcription of those genes. In TRAP1 knockdown cells, the amount of tyrosine-
phosphorylated STAT3, but not the total amount of tyrosine-phosphorylated STAT3, was 
significantly reduced. In addition, the promoter activity of the E2F1 gene was significantly 
reduced if the STAT3 recognition site was deleted and if TRAP1 was knocked down. These 
data indicate that TRAP1 regulates the tyrosine phopsphorylation status of STAT3, which 
controls the expression of E2F1, and thus modulates the transcription of N-cadherin. 
5.6 Role of the TRAP1-N-cadherin cascade in psychiatric disorders (Fig. 4G) 
Because N-cadherin is involved in the morphogenesis of synapses (Okamura et al., 2004; 
Togashi et al., 2002), the regulation of the morphology of dendritic spines by TRAP1 via N-
cadherin was analyzed in cultured hippocampal neurons. Spines are divided into 2 types 
based on morphology, namely: pedunculated and sessile with the former possessing a 
substantial stalk construction that is absent in the latter (Greg et al., 1999). In TRAP1 
knockdown neurons, spines were predominantly sessile. Only 20.8% of spines displayed a 
pedunculate morphology compared with 66.7% in control neurons. Functionally, N-
cadherin regulates synaptic plasticity; The activity dependent accumulation of N-cadherin  
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Fig. 4. TRAP1 is involved in cell-cell adhesion. A,B: Immunohistochemistry of TRAP1 
knockdown and control cells stained with an anti-TRAP1 antibody (red) and DAPI(blue). 
TRAP1 protein levels are markedly reduced in B. In addition, cells transfected with siTRAP1 
were dispersed throughout the dish (B), compared withcells transfected with control 
siRNAthat grew in aggregates resembling untransfected SH-SY5Y cells. C,D: TRAP1 
knockdown results in the down-regulation of N-cadherin. Immunohistochemistry of TRAP1 
knockdown cells (D) compared with that of control cells (C) stained with an anti-N-cadherin 
antibody (green) and DAPI (blue). In the TRAP1 knockdown cells (D), N-cadherin is 
remarkably decreased throughout the cytoplasm, including around the membrane where 
cell-adhesion takes place. C: Immunobloting of TRAP1 knockdown cells at 48 h after 
transfection with anti-TRAP1, E2F1 and GAPDH antibodies.E2F1 expression was 
significantly decreased in the TRAP1 knockdown cells, showing that TRAP1 knockdown 
decreases the transcription activity of the N-cadherin promoter. D: Immunoblotting of 
TRAP1 knockdown cells with anti-TRAP1, phosphorylated STAT3 (Tyr705) (p-Tyr STAT3), 
STAT3 and GAPDH antibodies 48h after transfection. The level of tyrosine-phosphorylated 
STAT was significantly reduced in the TRAP1 knockdown cells. D: Molecular pathway of 
the TRAP1-N-cadherin cascade. TRAP1 regulates the tyrosine phosphorylation of STAT3, 
which controls the expression of E2F, and thus, subsequently modulates the transcription of 
N-cadherin. As TRAP1 mutations are deeply involved in major depression, the disturbance 
of cell adhesion by the reduction of N-cadherin which causes abnormal neural circuit 
formation, may be  important in the pathogenesis of major depression. 
at synapse is essential for spine remodeling and long term potentiation, suggesting that N-
cadherin plays important roles in higher brain function such as learning and memory. It is 
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therefore likely that altered expression of N-cadherin may be associated with the 
pathogenesis of mental disorders.   
In support of this, we showed that 4 SNPs in the TRAP1 gene may be associated with the 
pathogenesis of mental disorders, particularly major depression, including 2 SNPs that 
cause an amino acid change in the TRAP1 protein:R07G (rs1 3926) and D395E (rs1 136948). 
Moreover, these 2 non-synonymous SNPs are located in the region critical for the binding of 
TRAP1 to TNFR1, suggesting that the binding affinity of TRAP1 to TNFR1 or the 
downstream signaling of TRAP1 might be altered in these disorders. 
6. Involvement of DISC1 in psychiatric disorders (Fig. 5) 
DISC1 has been identified as a potential susceptibility gene for major psychiatric disorders. 
Disruption of this gene by a balanced translocation (1:11,q42.1;q14.3) results in a predicted 
C-terminal truncation of the open reading frame. Furthermore, this anomaly is segregated 
with schizophrenia and affective disorders in a large Scottish family (Millar et al., 
2000,2001). A frameshift mutation of DISC1 has been identified in an American family with 
schizophrenia and schizoaffective disorder (Sach et al., 2005), and the association of the 
SNPs of DISC1 with schizophrenia, schizoaffetive disorder and bipolar disorder has also 
been suggested (Hodgkinson et al., 2004). 
6.1 Interacting partners bind to the area close to the translocation breakpoint of 
DISC1 
DISC1 has been proposed to be a multifunctional protein that interacts with multifunctional 
protein that interact with multiple proteins of the centrosome and cytoskeletal system at a 
distinct domain (Morris et al., 2003; Ozaki et al., 2003). The function of DISC1 could 
therefore be regulated by DISC1 binding proteins. The DISC1 binding partners, fasciculation 
and elongation protein zeta-1 (Fez1), DBZ and kendrin were identified using yeast 2-hybrid 
analysis. The interaction between DISC1 and Fez1, DISC1 and DBZ, and DISC1 and Kendrin 
were confirmed by immunoprecipitation assaysȐMatsuzaki & Tohyama, 2007, Miyoshi et 
al., 2003, Hattori et al., 2007ȑ. 
6.2 Role of DISC1-Fez1 interaction in psychiatric disorders (Miyoshi et al.,2003) 
The DISC1-Fez1 interaction identified in vitro was confirmed in vivo by showing the  co-
localization of DISC1 and Fez1 in neurons of the hippocampus, cerebral cortex and olfactory 
bulb. Analysis of the intracellular localization of DISC1 revealed that DISC1 and Fez1 co-
localize in growth cones in cultured hippocampal neurons. The interactions of these proteins 
are associated with F-actin. The finding that a molecular complex composed of DISC1, Fez1 
and actin is located in the growth cone of neurite suggests the  involvement of the DISC1-
Fez1 interaction in neurite extension. In support of this, both DISC1 and Fez1 were found to 
be expressed in the brain during an early ontogenetical stage Honda et al., 2004). The 
physiological role of the DISC1-Fez1 interaction in neuronal cells, especially at the stage of 
neurite outgrowth, was examined using PC12 cells. After stimulation with nerve growth 
factor (NGF), PC12 cells cease proliferation and begin to extend neuritis. The interaction 
between FLAG-tagged DISC1 and endogenous Fez1 was examined over the course of 
neuronal differentiation. The amount of Fez1 in immunoprecipitates obtained using an anti-
FLAG antibody was drastically increased upon NGF stimulation, suggesting that the DISC1-
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Fez1 interaction is up-regulated by NGF stimulation.. Furthermore, when treated with NGF, 
DISC1-stable lines exhibited enhanced neurite extension compared to mock-stable cells. 
These findings established that DISC1 participates in neurite outgrowth through its 
interaction with Fez1. In schizophrenia with DISC1 translocation carriers, in which Fez1 
cannot bind to DISC1 owing to its translocation, neuronal circuit formation may remain 
immature. In addition, an association between the SNPs of the Fez1 gene and schizophrenia 
has also been suggested in a Japanese population (Yamada et al., 2004). 
6.3 Role of the DISC1-Kendrin interaction in psychiatric disorders 
(Miyoshi et al., 2004; Shimizu et al. 2008) 
6.3.1 The carboxy-terminal region of DISC1 is essential for the DISC1-Kendrin 
interaction 
Kendrin, also referred to as pericentrin-B, is a calmodulin-binding protein localized 
specifically on centrosomes. Through the presence of the PACT domain, Kendrin is targeted 
to the centrosome. Co-localization of DISC1 and Kendrin was demonstrated in SH-SY5Y 
neuroblastoma cells transfected. In addition, co-localization of DISC1 and Kendrin at the 
centrosome was confirmed by immunohisotchemistry. DISC1 lacking the putative Kendrin 
binding region (amino acid 446-553) (KBR) is unable to target to the centrosome and 
distributes diffusely throughout the cytoplasm, showing that interaction of DISC1 with 
Kendrinis essential for its centrosomal localization. A direct yeast 2-hybrid interaction assay 
suggested that a short fragment of amino acids 446-533 of DISC1 constituting the binding 
region (KBR) was essential for the interaction with Kendrin. A subsequent study using 
immunoprecipitation assays in HEK293 cells in which Kendrin was endogenously 
expressed confirmed that KBR is critical for the interaction with Kendrin as described below. 
Cells were transiently transfected with expression vectors for HA-tagged full-length DISC1 
(DISC1-HA) and the HA-tagged DISC1 deletion muctant lacking the KBR (DSC1⊿KBR-HA). 
Endogenous Kendrin was coimmunoprecipitated with DISC1-HA, but not with 
DISC1⊿KBR-HA. These findings indicate that KBR is the binding region of DISC1 to 
Kendrin. To examine whether KBR itself could bind to Kendrin, several DISC1 deletion 
mutants were prepared: GDBP (amino acids 348-597－FLAG, BPC (amino acids 598-854)-
FLAG, BR (amino acids 446-633)-FLAG, KBR-FLAG and KBRC (amino acids 446-854)-FLAG. 
Surprisingly, endogenous Kendrin was detected in immunoprecipitates from cells 
transfected with KBRC-FLAG, but it was barely detected in  immunoprecipitates from cells 
transfected with GDBP-FLAG, BPC-FLAG, BR-FRAG or KBR-FLAG. These findings confirm 
KBR as the Kendrin binding region for DISC1 to Kendrin, but also show that the binding to 
Kendrin is enhanced remarkably in the presence of the carboxy-terminal region downstream 
of KBR. Thus, KBR is required but not sufficient for the interaction, and the carboxy-
terminal region of DISC1 is also indispensable for the binding to Kendrin. 
6.3.2 The carboxy-terminal region of DISC1 is required for the localization of DISC1 to 
the centrosome 
Next, we determined which part of DISC1 is indispensable for co-localization of DISC1 with 
Kendrin at the centrosome. KBRC-FLAG showed a diffuse pattern in the cytoplasm but 
clearly revealed a strong ‘dot' pattern in the perinuclear area. The merged image of KBRC-
FLAG and Kendrin showed that they were colocalized at the centrosome. On the other 
hand, localization of KBR-FLAG showed a diffuse distribution pattern in the nucleus and 
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cytoplasm without strong staining at the centrosome. Staining of BR-FLAG and GDBP-
FLAG was characterized by a small punctate distribution pattern, while BPC-FLAG 
exhibited a diffuse distribution in the cytoplasm. However, BPC-FLAG was not detected at 
the centrosome. Taken together, these findings demonstrate that the carboxy-terminal half 
of the DISC1 protein containing KBR and the downstream region of KBR are necessary and 
sufficient to target the DISC1 protein to the centrosome.  
6.3.4 Inhibition of the DISC1-Kendrin interaction perturbs the microtubule network 
formation 
The interaction of DISC1 with Kendrin at the centrosome and the key role of Kendrin in 
microtubule nucleation at the centrosome suggest that the interaction between DISC1 and 
Kendrin may affect microtubule network formation. The DISC1-binding region of Kendrin 
(DBR) (amino acids 2918-305) was first identified. To inhibit the DISC1-Kendrin interaction 
specifically at the centrosome, a FLAG-tagged DRB-PACT (DBR-PACT-FLAG) construct 
was prepared including DBR and PACT (a conserved centrosomal targeting motif in CG-
NAP and pericentrin). Microtubule aster formation was then observed in COS cells 
transfected with either the DBZ-PACT-FLAG or PACT-FLAG expression vector. Mock-
transfected cells showed microtubule aster formation at the centrosome. However, over-
expression of DBR-PACT-FLAG resulted in a significant decrease in the percentages of cells 
containing the microtubule aster compared with cells expressing PACT-FLAG. In addition, 
over-expression of DISC1 ⊿KBR-FLAG resulted in a significant decrease in the percentage of 
cells containing the microtubule aster compared with mock-transfected cells. These results 
show that the DISC1-Kendrin interaction is involved in brain maturation through the 
regulation of microtubule organization. 
6.3.5 Role of the DISC1-Kendrin interaction in mental disorders 
Over-expression of the DISC1-binding region of Kendrin perturbed the normal distribution 
of the stabilized microtubule network. The over-expression of DISC1 lacking the Kendrin 
binding site caused an impairment in microtubule aster formation. Carriers of the 
chromosomal translocation that segregates with mental diseases are expected to produce the 
truncated mutant DISC1 protein that lacks the carboxy-terminal region, or to have a reduced 
expression of the DISC1 protein. In the case of truncated mutant protein expression, this 
protein would not be able to target to the centrosome and interact with Kendrin, which 
might induce dysfunction of the microtubule network formation. Loss of DISC1 protein 
expression could lead to the dysfunction of microtubules by disrupting the DISC1-Kendrin 
interaction. In addition, involvement of Kendrin in olfactory cilia assembly was also 
reported (Miyoshi et al., 2009). Thus, the DISC1-Kendrin interaction plays a role in neuronal 
development by regulating microtubule organization, showing that mental diseases derived 
from DISC1 dysfunction are neurodevelopmental disease. In addition, our recent analysis 
showed an association between SNPs of the Kendrin gene and bipolar diseases (Anitha et 
al., 2005). 
6.4 Role of DISC1 and its binding proteins with special reference to psychiatric 
disorders 
The present review summarize results showing that DISC1 functions in neural network 
formation by interacting with several binding partners, including Fez1, DBZ, and 
www.intechopen.com
 
Psychiatric Disorders – Trends and Developments 
 
462 
Kendrin, which binds to the area near the translocation site of DISC1.  DISC1 interactions, 
including DISC1-Fez1, DISC1-DBZ and DISC1-Kendrin, all play a key role in neuronal 
development. Other groups have identified additional DISC1 interaction partner such as 
NudE-like (NUDEL) (Morris et al., 200; Ozeki et al., 2003), lissenchphaly-1 (LIS1) 
(Brandron et al., 2004), phosphodiesterase 4B (PDE4B) (Millar et al., 2005), glycogen 
synthase kinase 3 (GSK3) (Mao et al., 2009), the motor protein dynein and growth factor 
receptor bound protein 2 (Grb2) (Shinoda et al., 2007;Taya et al., 2007), and these binding 
partners suggested the functional involvement of DISC1 in neural development. DISC1 
therefore plays crucial roles in brain development by affecting neuronal migration, 
neurite outgrowth and neural maturation through its interaction with several cytoskeletal 
proteins. 
 
 
Fig. 5. DISC1 binding proteins that bind to an area near the translocation and their function.  
The binding between DISC1 and these molecules play a role in neurodevelopment. 
Accordingly mental disorders in which these molecules are implicated could be considered 
neurodevelopmental diseases. 
7. Conclusion 
The results summarized in this review indicate that the TRAP1 cascade, PACAP-stathmin1 
cascade, PACAP-DBZ/DISC1 cascade, Dysbindin-MARCKS cascade, DISC1-Fez1 
interaction and DISC1-Kendrin interaction are all involved in neural development. In 
addition, the molecules mentioned above are associated with schizophrenia or bipolar 
disease, showing that the neural development that is associated with these systems is 
disturbed in the brains of patients with either of these disease. 
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